Results 101 to 110 of about 8,187 (238)
Cefiderocol represents a significant advancement in the treatment of multidrug-resistant Gram-negative bacterial infections. Its unique uptake mechanism, leveraging bacterial iron transport pathways for membrane permeation, sets it apart from ...
M. Z. Salleh
semanticscholar +1 more source
INTRODUCTION The increase in the population of immunocompromised patients due to advances in management of end-stage diseases and transplants poses challenges in treating infections caused by multi-drug resistant (MDR) pathogens.
Sarah Soueges +24 more
semanticscholar +1 more source
Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa [PDF]
Objectives: The main aim of this study was to evaluate the antibiofilm activity of cefiderocol alone and in combination with imipenem vs. sessile cells of Pseudomonas aeruginosa, assessing a potential synergistic bactericidal effect.
Cesta N. +16 more
core +1 more source
Background Carbapenemase-producing Enterobacterales (CPE) pose difficult therapeutic challenges. We aimed to characterize antimicrobial resistance profiles of CPE in our centre.
I. Baltas, Trupti Patel, A. Soares
semanticscholar +1 more source
In vitro activity of cefiderocol against nosocomial Acinetobacter baumannii
The emergence and spread of third-/fourth-generation cephalosporin and/or carbapenem-resistant Acinetobacter baumannii have become a significant global public health concern, making new treatment alternatives necessary.
Barbara Ymaña +20 more
doaj +1 more source
Supplemental Digital Content is Available in the Text.
M. Gatti +6 more
semanticscholar +1 more source
Cefiderocol, a novel siderophore cephalosporin, demonstrates promising in vitro activity against multidrug-resistant Gram-negative bacteria, including carbapenemase-producing strains.
Richard Kriz +10 more
semanticscholar +1 more source
Gram-negative metallo-β-lactamase-producing bacteria can be extremely problematic, especially when found to be extensively drug-resistant (XDR). Cefiderocol is a novel antimicrobial that has been shown to overcome most carbapenemases, with very rare ...
Kevin R. Barker +5 more
doaj +1 more source
BACKGROUND The best treatment for carbapenem-resistant Acinetobacter baumannii (CRAB) infections is still a matter of debate. OBJECTIVES To describe the outcomes of patients treated with cefiderocol for CRAB infections, and to compare the efficacy of ...
Lorenzo Onorato +3 more
semanticscholar +1 more source
Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak
Variable outcomes have been reported with cefiderocol in infections due to carbapenem-resistant Acinetobacter baumannii (CRAB). Nonetheless, it may be the only option for metallo-beta-lactamase-producing strains.
Francesco Peracchi +10 more
core +1 more source

